CELANESE CORP (1CE.MI) Fundamental Analysis & Valuation

BIT:1CE • US1508701034

Current stock price

43.53 EUR
-4.47 (-9.31%)
Last:

This 1CE.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. 1CE.MI Profitability Analysis

1.1 Basic Checks

  • 1CE had positive earnings in the past year.
  • In the past year 1CE had a positive cash flow from operations.
  • In multiple years 1CE reported negative net income over the last 5 years.
  • Of the past 5 years 1CE 4 years had a positive operating cash flow.
1CE.MI Yearly Net Income VS EBIT VS OCF VS FCF1CE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1.2 Ratios

  • With a Return On Assets value of -13.95%, 1CE is not doing good in the industry: 79.71% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -78.22%, 1CE is doing worse than 88.41% of the companies in the same industry.
  • The Return On Invested Capital of 1CE (3.41%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1CE is below the industry average of 7.16%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.41%
ROA(3y)-1.58%
ROA(5y)3.65%
ROE(3y)-10.4%
ROE(5y)9.5%
ROIC(3y)3.74%
ROIC(5y)6.13%
1CE.MI Yearly ROA, ROE, ROIC1CE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • 1CE has a Operating Margin (8.72%) which is comparable to the rest of the industry.
  • 1CE's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.33%, 1CE is doing worse than 68.12% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1CE has declined.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-17.45%
OM growth 5Y-8.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.93%
GM growth 5Y-2.17%
1CE.MI Yearly Profit, Operating, Gross Margins1CE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

3

2. 1CE.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CE is destroying value.
  • Compared to 1 year ago, 1CE has about the same amount of shares outstanding.
  • 1CE has less shares outstanding than it did 5 years ago.
  • 1CE has a worse debt/assets ratio than last year.
1CE.MI Yearly Shares Outstanding1CE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
1CE.MI Yearly Total Debt VS Total Assets1CE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • 1CE has an Altman-Z score of 1.50. This is a bad value and indicates that 1CE is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of 1CE (1.50) is worse than 73.91% of its industry peers.
  • 1CE has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as 1CE would need 12.55 years to pay back of all of its debts.
  • 1CE has a Debt to FCF ratio of 12.55. This is comparable to the rest of the industry: 1CE outperforms 49.28% of its industry peers.
  • 1CE has a Debt/Equity ratio of 2.99. This is a high value indicating a heavy dependency on external financing.
  • 1CE's Debt to Equity ratio of 2.99 is on the low side compared to the rest of the industry. 1CE is outperformed by 89.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.5
ROIC/WACC0.48
WACC7.08%
1CE.MI Yearly LT Debt VS Equity VS FCF1CE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • 1CE has a Current Ratio of 1.63. This is a normal value and indicates that 1CE is financially healthy and should not expect problems in meeting its short term obligations.
  • 1CE's Current ratio of 1.63 is in line compared to the rest of the industry. 1CE outperforms 49.28% of its industry peers.
  • A Quick Ratio of 1.04 indicates that 1CE should not have too much problems paying its short term obligations.
  • The Quick ratio of 1CE (1.04) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
1CE.MI Yearly Current Assets VS Current Liabilites1CE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. 1CE.MI Growth Analysis

3.1 Past

  • 1CE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.86%.
  • The earnings per share for 1CE have been decreasing by -12.03% on average. This is quite bad
  • The Revenue has decreased by -7.16% in the past year.
  • The Revenue has been growing by 11.03% on average over the past years. This is quite good.
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.75% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, 1CE will show a small growth in Revenue. The Revenue will grow by 1.44% on average per year.
EPS Next Y38.2%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
EPS Next 5Y25.75%
Revenue Next Year0.13%
Revenue Next 2Y1.6%
Revenue Next 3Y0.67%
Revenue Next 5Y1.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1CE.MI Yearly Revenue VS Estimates1CE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
1CE.MI Yearly EPS VS Estimates1CE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

8

4. 1CE.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.77 indicates a correct valuation of 1CE.
  • 1CE's Price/Earnings ratio is rather cheap when compared to the industry. 1CE is cheaper than 88.41% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.60. 1CE is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.25, the valuation of 1CE can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, 1CE is valued cheaper than 97.10% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. 1CE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.77
Fwd PE 9.25
1CE.MI Price Earnings VS Forward Price Earnings1CE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1CE's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1CE indicates a rather cheap valuation: 1CE is cheaper than 98.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.5
EV/EBITDA 10.41
1CE.MI Per share data1CE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1CE's earnings are expected to grow with 29.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y31.42%
EPS Next 3Y29.62%

0

5. 1CE.MI Dividend Analysis

5.1 Amount

  • 1CE has a yearly dividend return of 0.24%, which is pretty low.
  • 1CE's Dividend Yield is slightly below the industry average, which is at 2.36.
  • Compared to an average S&P500 Dividend Yield of 1.90, 1CE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.24%

5.2 History

  • The dividend of 1CE decreases each year by -45.65%.
Dividend Growth(5Y)-45.65%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1CE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.78%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
1CE.MI Yearly Income VS Free CF VS Dividend1CE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B

1CE.MI Fundamentals: All Metrics, Ratios and Statistics

CELANESE CORP

BIT:1CE (2/18/2026, 7:00:00 PM)

43.53

-4.47 (-9.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17
Earnings (Next)05-04
Inst Owners103.64%
Inst Owner ChangeN/A
Ins Owners0.29%
Ins Owner ChangeN/A
Market Cap4.77B
Revenue(TTM)9.54B
Net Income(TTM)-3.09B
Analysts73.33
Price Target55.83 (28.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.24%
Yearly Dividend0.1
Dividend Growth(5Y)-45.65%
DP-2.78%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-36.85%
EPS NQ rev (3m)-36.85%
EPS NY rev (1m)-20.74%
EPS NY rev (3m)-20.74%
Revenue NQ rev (1m)-5.72%
Revenue NQ rev (3m)-5.72%
Revenue NY rev (1m)-5.63%
Revenue NY rev (3m)-5.63%
Valuation
Industry RankSector Rank
PE 12.77
Fwd PE 9.25
P/S 0.58
P/FCF 5.5
P/OCF 4.05
P/B 1.42
P/tB N/A
EV/EBITDA 10.41
EPS(TTM)3.41
EY7.83%
EPS(NY)4.71
Fwd EY10.81%
FCF(TTM)7.92
FCFY18.2%
OCF(TTM)10.74
OCFY24.67%
SpS75.12
BVpS30.59
TBVpS-26.53
PEG (NY)0.33
PEG (5Y)N/A
Graham Number48.44
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.41%
ROICexc 3.7%
ROICexgc 6.49%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)-1.58%
ROA(5y)3.65%
ROE(3y)-10.4%
ROE(5y)9.5%
ROIC(3y)3.74%
ROIC(5y)6.13%
ROICexc(3y)4.01%
ROICexc(5y)6.53%
ROICexgc(3y)7.88%
ROICexgc(5y)10.88%
ROCE(3y)5.03%
ROCE(5y)8.35%
ROICexgc growth 3Y-15.4%
ROICexgc growth 5Y-7.22%
ROICexc growth 3Y-10.69%
ROICexc growth 5Y-13.63%
OM growth 3Y-17.45%
OM growth 5Y-8.69%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.93%
GM growth 5Y-2.17%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.5
F-Score3
WACC7.08%
ROIC/WACC0.48
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.86%
EPS 3Y-36.78%
EPS 5Y-12.03%
EPS Q2Q%-53.79%
EPS Next Y38.2%
EPS Next 2Y31.42%
EPS Next 3Y29.62%
EPS Next 5Y25.75%
Revenue 1Y (TTM)-7.16%
Revenue growth 3Y-0.45%
Revenue growth 5Y11.03%
Sales Q2Q%-7%
Revenue Next Year0.13%
Revenue Next 2Y1.6%
Revenue Next 3Y0.67%
Revenue Next 5Y1.44%
EBIT growth 1Y-23%
EBIT growth 3Y-17.82%
EBIT growth 5Y1.39%
EBIT Next Year75.34%
EBIT Next 3Y25.85%
EBIT Next 5Y20.79%
FCF growth 1Y21.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.61%
OCF growth 3YN/A
OCF growth 5YN/A

CELANESE CORP / 1CE.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CE stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CE.MI.


What is the valuation status for 1CE stock?

ChartMill assigns a valuation rating of 7 / 10 to CELANESE CORP (1CE.MI). This can be considered as Undervalued.


How profitable is CELANESE CORP (1CE.MI) stock?

CELANESE CORP (1CE.MI) has a profitability rating of 3 / 10.


What is the valuation of CELANESE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CELANESE CORP (1CE.MI) is 12.77 and the Price/Book (PB) ratio is 1.42.


How financially healthy is CELANESE CORP?

The financial health rating of CELANESE CORP (1CE.MI) is 3 / 10.